stella
beta
ZG006 and ZG005 in Participants With Small Cell Lung Cancer or Neuroendocrine Carcinoma — Stella
Recruiting
Back to Small Cell Lung Cancer trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
China
Sun Yat-sen University Cancer Center, Guanzhou, Guangdong
View full record on ClinicalTrials.gov